NPI registry status
Active
2026 NPPES data Allergy & Immunology Physician NPI 1174530414 MD
Verify on CMS → Matthew Rank, MD
Allergy & Immunology Physician in Scottsdale, Arizona.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,412 in Allergy & Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
689
Medicare Part D claims · 120 beneficiaries · Allergy & Immunology Physician avg: 788
MIPS score
78.6/100
▼ 5 pts below national avg 83.5 · Above neutral
What the federal data shows
Matthew Rank, MD reported a CMS MIPS final score of 78.6/100 - below the 83.5 national average - and filed 689 Medicare Part D claims in 2024.
- 78.6/100
- MIPS score · -5 vs avg
- 689
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥23rd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Rank, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174530414), first enumerated 08/01/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 689 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 78.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1174530414 · Allergy & Immunology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1174530414
- ENUM-LEGACY 2006
- TAX-NARROW 3,412
- MIPS-BELOW 78.6/100
- RX-LIGHT 689
- BOOK-THIN 71 in Arizona
- PHOTO-FINISH Sokun Bhatti · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Rank · this prov…
Rank · this provider
78.6 MIPS pts
- Michelle Squadri…
Michelle Squadrito
78.6 MIPS pts
- Sokun Bhatti · n…
Sokun Bhatti
78.6 MIPS pts
- Thomas Graves · …
Thomas Graves
78.6 MIPS pts
- Junfang Jiao · n…
Junfang Jiao
78.6 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Matthew Rank, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
79 ≥ 23rd percentile 23% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Matthew Rank, MD sits
This provider among allergy & immunology physician peers
Across the 659 allergy & immunology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Rank, MD writes more Part D claims than 49% of them and scores higher on MIPS quality than 41% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one allergy & immunology physician peer from a representative sample of 60; the gold marker is Matthew Rank, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Matthew Rank, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Rank, MD?
Near national averagePrimary specialty
Allergy & Immunology Physician
Medicare Part D claims
689 13% vs specialty avg
MIPS final score
78.6/100 4.9 pts vs avg
Specialty distribution in Arizona
How Allergy & Immunology Physician compares to other specialties among Arizona providers
Medicare quality performance, MIPS
Matthew Rank, MD's 2023 MIPS final score plotted against the Allergy & Immunology Physician national average
- MIPS Final Score
- 78.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174530414 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/01/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
78.5864
Final Score
Measured-score avg: 83.5
69.056
Quality
59.5653
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Matthew Rank, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mayo Clinic Arizona
Scottsdale, AZ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
689
Total Claims
$800K
Total Drug Cost
120
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,072.767
- Total Day Supply
- 28,987
- Generic Drug Cost
- $25K
- Antibiotic Claims
- 25
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 1.29
- Gender Split
- 59% female / 41% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Rank, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ipratropium Bromide
Ipratropium Bromide
71 claims
- Montelukast Sodium
Montelukast Sodium
65 claims
- Prednisone
Prednisone
64 claims
- Azelastine Hcl
Azelastine Hcl
39 claims
- Dupixent Pen
Dupixent Pen
39 claims
- Spiriva Respimat
Spiriva Respimat
32 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
31 claims
- Arnuity Ellipta 25
Arnuity Ellipta
25 claims
| Drug | Claims |
|---|---|
| Ipratropium Bromide | 71 |
| Montelukast Sodium | 65 |
| Prednisone | 64 |
| Azelastine Hcl | 39 |
| Dupixent Pen Dupilumab | 39 |
| Spiriva Respimat Tiotropium Bromide | 32 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 31 |
| Arnuity Ellipta Fluticasone Furoate | 25 |
| Dupixent Syringe Dupilumab | 25 |
| Nucala Mepolizumab | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How Matthew Rank, MD fits within the Allergy & Immunology Physician landscape nationally.
3,412
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
788
Avg Claims per Provider
Matthew Rank, MD's 689 claims are below the specialty average of 788.
Nationwide Allergy & Immunology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rank, both outside Arizona so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (78.6 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy & Immunology Physician Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Rank.
One of 71 Allergy & Immunology Physician providers enrolled in Arizona, 5 are shown here.
Dr. Housam Alasaly
M.D.
Phoenix, AZ
Dr. Miriam Anand
M.D.
Tempe, AZ
Dr. Natarajan Asokan
M.D.
Kingman, AZ
Dr. Martin Bartels
MD
Tucson, AZ
Dr. Kevin Boesel
MD
Peoria, AZ
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Rank, MD's specialty? ▼
Matthew Rank, MD specializes in Allergy & Immunology Physician and practices in Scottsdale, Arizona. Credentials: MD.
How much does Matthew Rank, MD prescribe under Medicare Part D? ▼
In 2024, Matthew Rank, MD wrote 689 Medicare Part D claims totaling $800K in drug costs for 120 beneficiaries.
What is Matthew Rank, MD's Medicare quality score? ▼
Matthew Rank, MD has a CMS MIPS Final Score of 78.6/100 (Quality: 69.1, Cost: 59.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Rank, MD located? ▼
Matthew Rank, MD is located at 13400 E SHEA BLVD, Scottsdale, AZ, 85259. Phone: (480) 301-8000.
What is Matthew Rank, MD's NPI number? ▼
Matthew Rank, MD's National Provider Identifier (NPI) is 1174530414, issued on 08/01/2006.
How many Allergy & Immunology Physician providers are there in the US? ▼
There are 3,412 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 788 Medicare Part D claims per year.
What drugs does Matthew Rank, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Rank, MD's most frequently prescribed drugs include Ipratropium Bromide, Montelukast Sodium, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Rank, MD accept Medicare? ▼
Matthew Rank, MD appears in CMS Medicare data with 689 Part D claims and 120 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Rank, MD's credentials? ▼
Matthew Rank, MD's NPI is 1174530414 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.